| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000035003 |
| Receipt No. | R000039903 |
| Official scientific title of the study | Observational study of the correlation between the geriatric assessment tools and prognosis of the geriatric patients with multiple myeloma (prospective observational study) |
| Date of disclosure of the study information | 2018/12/15 |
| Last modified on | 2018/12/27 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Observational study of the correlation between the geriatric assessment tools and prognosis of the geriatric patients with multiple myeloma (prospective observational study) | |
| Title of the study (Brief title) | Observational study of the correlation between the geriatric assessment tools and prognosis of the geriatric patients with multiple myeloma (prospective observational study) | |
| Region |
|
|
| Condition | ||
| Condition | multiple myeloma | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We confirm whether the geriatric assessment tool can be multiple myeloma patients prognostic prediction |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 5 years survival rate stratified by geriatric assessment tool |
| Key secondary outcomes | monthly hospital days stratified by geriatric assessment tool
decrease rate of the score of EQ-5D-5L stratified by geriatric assessment tool remission rate by treatment intensity stratified by geriatric assessment tool survival rate by treatment intensity stratified by geriatric assessment tool |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 65 years of age or older
patients diagnosed with multiple myeloma patients who got written informed consent |
|||
| Key exclusion criteria | patients who treat chemotherapy for hematological malignancy | |||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Suyama Takuya |
| Organization | Hitachi general hospital |
| Division name | hematology,oncology |
| Address | 2-1-1 Jonan-cho,Hitachi City,Ibaraki prefecture |
| TEL | 0294231111 |
| sutaku2468@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Suyama Takuya |
| Organization | Hitachi general hospital |
| Division name | hematology,oncology |
| Address | 2-1-1 Jonan-cho,Hitachi City,Ibaraki prefecture |
| TEL | 0294231111 |
| Homepage URL | |
| sutaku2468@yahoo.co.jp | |
| Sponsor | |
| Institute | Hitachi general hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hitachi general hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 日立総合病院(茨城県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | observational study
all patients who met the selection criteria in patients who visited our hospital forom December 2018 to December 2026 Items to be measured:age,sex,PS,G8,R-ISS, Charlson comobidity index,EQ-5D-5L(registration,Half a year, 1 year, 2 year, 3 year, 4 year, 5 year),serum Alb,hospital days,Chemotherapy, treatment effect, presence or absence of relapse, survival date, date of death |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039903 |